Gefticip (250 mg)

CIPLA LTD.

GEFTICIP contains Drug / Molecule called “GEFITINIB”.Gefitinib is an anilinoquinazoline. It attaches to epidermal growth factor receptors (EGFRs), thereby blocking the attachment of EGF and the activation of tyrosine kinase.It targets the mutant protein in the cancerous cells and destroys them.

Category:

Indication

Gefticip is used for the treatment of locally advanced or metastatic Non-Small Cell Lung Cancer.

Note

Precaution

  • Gefticip is a prescription drug and should be used under proper medical guidance and advice.
  • Contraindicated recommended for use during pregnancy.

Related products